Philippe Voyer Selected Research

Long-Term Care

6/2022	Assessing facilitating conditions and barriers for innovation implementation in Canadian long-term care homes: a research protocol.
11/2021	The PREvention Program for Alzheimer's RElated Delirium (PREPARED) cluster randomized trial: a study protocol.
1/2017	Use of medications that antagonize mediators of inflammatory responses may reduce the risk of delirium in older adults: a nested case-control study.
1/2016	Assessment of inattention in the context of delirium screening: one size does not fit all!
12/2014	Six-month outcomes of co-occurring delirium, depression, and dementia in long-term care.
8/2014	Nursing documentation in long-term care settings: New empirical evidence demands changes be made.
7/2014	Core symptoms not meeting criteria for delirium are associated with cognitive and functional impairment and mood and behavior problems in older long-term care residents.
6/2014	[Factorial structure of the French version of the Nursing Home Behavior Problem Scale].
1/2014	Feasibility and acceptability of a delirium prevention program for cognitively impaired long term care residents: a participatory approach.
6/2013	Symptoms of delirium predict incident delirium in older long-term care residents.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Voyer Research Topics

Disease

28	Delirium 11/2021 - 05/2007
13	Dementia (Dementias) 01/2018 - 02/2008
6	Cognitive Dysfunction 01/2021 - 03/2003
4	Anxiety Disorders (Anxiety Disorder) 06/2011 - 01/2005
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2006 - 01/2005
2	Neurocognitive Disorders (Clerambault Syndrome) 01/2022 - 01/2021
2	Confusion (Bewilderment) 12/2012 - 03/2009
2	Mania (Manias) 07/2010 - 12/2008
2	Substance-Related Disorders (Drug Abuse) 06/2010 - 09/2004
1	COVID-19 06/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Consciousness Disorders 07/2014
1	Wounds and Injuries (Trauma) 06/2007

Drug/Important Bio-Agent (IBA)

8	BenzodiazepinesIBA 07/2010 - 03/2003
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 12/2014 - 03/2009
3	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 11/2005
3	Pharmaceutical PreparationsIBA 07/2015 - 01/2005
1	SDMIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 06/2011
1	antineoplaston A10 (A 10)IBA 05/2011
1	Narcotics (Narcotic Analgesics)IBA 05/2007

Therapy/Procedure

32	Long-Term Care 06/2022 - 11/2005
6	Home Nursing (Nursing, Home) 01/2018 - 01/2006
2	Length of Stay 01/2021 - 01/2018
2	Activities of Daily Living (ADL) 05/2011 - 05/2007
1	Polypharmacy 07/2015
1	Respite Care 03/2012
1	Pain Management 05/2007